c-Cbl Is Involved in Met Signaling in B Cells and Mediates Hepatocyte Growth Factor-Induced Receptor Ubiquitination

Autor: Marcel Spaargaren, Steven T. Pals, Esther A. Beuling, Jannie Borst, Esther P. M. Tjin, T. E. I. Taher
Přispěvatelé: Dermatology, Pathology
Rok vydání: 2002
Předmět:
Ubiquitin-Protein Ligases
Immunology
SRC Family Tyrosine Kinase
Proto-Oncogene Proteins c-fyn
Proto-Oncogene Mas
environment and public health
Receptor tyrosine kinase
Substrate Specificity
Ligases
Phosphatidylinositol 3-Kinases
chemistry.chemical_compound
FYN
LYN
Proto-Oncogene Proteins
hemic and lymphatic diseases
Tumor Cells
Cultured

medicine
Animals
Humans
Immunology and Allergy
Proto-Oncogene Proteins c-cbl
Phosphorylation
Phosphotyrosine
Ubiquitins
Adaptor Proteins
Signal Transducing

B-Lymphocytes
biology
Hepatocyte Growth Factor
Cell Membrane
Nuclear Proteins
Tyrosine phosphorylation
Proto-Oncogene Proteins c-met
enzymes and coenzymes (carbohydrates)
src-Family Kinases
chemistry
Acetylation
COS Cells
biology.protein
Cancer research
Hepatocyte growth factor
biological phenomena
cell phenomena
and immunity

Signal Transduction
medicine.drug
Zdroj: Journal of immunology (Baltimore, Md., 169(7), 3793-3800. American Association of Immunologists
ISSN: 1550-6606
0022-1767
Popis: Hepatocyte growth factor/scatter factor (HGF) and its receptor tyrosine kinase Met are key regulators of epithelial motility and morphogenesis. Recent studies indicate that the HGF/Met pathway also plays a role in B cell differentiation, whereas uncontrolled Met signaling may lead to B cell neoplasia. These observations prompted us to explore HGF/Met signaling in B cells. In this study, we demonstrate that HGF induces strong tyrosine phosphorylation of the proto-oncogene product c-Cbl in B cells and increases Cbl association with the Src family tyrosine kinases Fyn and Lyn, as well as with phosphatidylinositol-3 kinase and CrkL. In addition, we demonstrate that c-Cbl mediates HGF-induced ubiquitination of Met. This requires the juxtamembrane tyrosine Y1001 (Y2) of Met, but not the multifunctional docking site (Y14/15) or any additional C-terminal tyrosine residues (Y13–16). In contrast to wild-type c-Cbl, the transforming mutants v-Cbl and 70Z/3 Cbl, which lack the ubiquitin ligase RING finger domain, suppress Met ubiquitination. Our findings identify c-Cbl as a negative regulator of HGF/Met signaling in B cells, mediating ubiquitination and, consequently, proteosomal degradation of Met, and suggest a role for Cbl in Met-mediated tumorigenesis.
Databáze: OpenAIRE